Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Cash from Operations (2010 - 2025)

Siga Technologies' (SIGA) quarterly Cash from Operations came in at -$9.8 million in Q3 2025, down 32.92% on a YoY basis from -$14.6 million in Q3 2024, and down 115.56% quarter-over-quarter from $63.1 million in Q2 2025.

Analysis

Siga Technologies (SIGA) Cash from Operations (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Cash from Operations for 16 consecutive years, with -$9.8 million the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations fell 32.92% year-over-year to -$9.8 million; the trailing twelve-month figure through Sep 2025 stood at $116.6 million (up 63.17% YoY), and the FY2024 full-year result was $48.8 million, down 48.56% from the prior year.
  • Cash from Operations eased to -$9.8 million in Q3 2025 per SIGA's latest filing, from $63.1 million in the prior quarter.
  • Across five years, Cash from Operations topped out at $79.0 million in Q4 2023 and bottomed at -$9.8 million in Q3 2025.
  • Historically, Cash from Operations has averaged $13.5 million across 5 years, with a median of -$1.4 million in 2021.
  • The widest YoY moves for Cash from Operations: up 1279.83% in 2022, down 393.58% in 2022.
  • Over 5 years, Cash from Operations stood at $16.1 million in 2021, then plunged by 150.34% to -$8.1 million in 2022, then surged by 1074.95% to $79.0 million in 2023, then decreased by 28.75% to $56.3 million in 2024, then plunged by 117.43% to -$9.8 million in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods registered -$9.8 million, $63.1 million, and $7.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 8.62 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 3.44 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 5.88 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 835.00 Mn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 3.44 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn - -387.32 Mn
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 507.66 Mn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn 313.60 Mn
10 Siga Technologies 235.60 Mn 80.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -9.81 Mn
Jun 30, 2025 63.08 Mn
Mar 31, 2025 7.06 Mn
Dec 31, 2024 56.31 Mn
Sep 30, 2024 -7.38 Mn
Jun 30, 2024 5.95 Mn
Mar 31, 2024 -6.12 Mn
Dec 31, 2023 79.03 Mn
Sep 30, 2023 -5.10 Mn
Jun 30, 2023 -3.58 Mn
Mar 31, 2023 24.45 Mn
Dec 31, 2022 -8.11 Mn
Sep 30, 2022 -4.78 Mn
Jun 30, 2022 -2.21 Mn
Mar 31, 2022 56.71 Mn
Dec 31, 2021 16.10 Mn
Sep 30, 2021 1.63 Mn
Jun 30, 2021 -1.43 Mn
Mar 31, 2021 -4.81 Mn
Dec 31, 2020 45.95 Mn